Open Access

Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells

  • Authors:
    • Juan Martín Arriaga
    • Alicia Inés Bravo
    • José Mordoh
    • Michele Bianchini
  • View Affiliations

  • Published online on: April 3, 2017     https://doi.org/10.3892/or.2017.5547
  • Pages: 2633-2651
  • Copyright: © Arriaga et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Metallothioneins (MTs) are a family of low-molecular-weight, cysteine-rich proteins involved in zinc and redox metabolism, that are epigenetically downregulated during colorectal cancer (CRC) progression, but may be re-induced with a variety of agents. Since loss of MT expression is associated with a worse prognosis, in the present study we investigated the effects of overexpression of the most significantly downregulated isoform in CRC, namely MT1G, on the HT-29 cell line. Overexpression of MT1G resulted in xenograft tumors with an aberrant morphology, characterized by an evident increase in mucin-containing cells that were identified as goblet cells under electron microscopy. Immunohistochemical detection of CDX2 and cytokeratin 20 was also increased, as were goblet‑cell and enterocyte-specific genes by qRT-PCR. Microarray analysis of gene expression confirmed the alteration of several differentiation signaling pathways, including the Notch pathway. Using sodium butyrate and post-confluent growth as inducers of differentiation, we demonstrated that MT1G does indeed play a functional role in promoting goblet over enterocyte differentiation in vitro. Labile zinc is also induced upon differentiation of CRC cells, functionally contributing to enterocyte over goblet differentiation, as revealed using zinc‑specific chelating agents. Overall, our results uncover a new tumor-suppressor activity of MT1G in promoting the differentiation of at least some CRC tumors, and implicate MTs and zinc signaling as new players in colorectal differentiation. This further contributes to the hypothesis that re-induction of MTs may have therapeutic value by diminishing the aggressiveness of CRC tumors.
View Figures
View References

Related Articles

Journal Cover

May-2017
Volume 37 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Arriaga JM, Bravo AI, Mordoh J and Bianchini M: Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells. Oncol Rep 37: 2633-2651, 2017
APA
Arriaga, J.M., Bravo, A.I., Mordoh, J., & Bianchini, M. (2017). Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells. Oncology Reports, 37, 2633-2651. https://doi.org/10.3892/or.2017.5547
MLA
Arriaga, J. M., Bravo, A. I., Mordoh, J., Bianchini, M."Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells". Oncology Reports 37.5 (2017): 2633-2651.
Chicago
Arriaga, J. M., Bravo, A. I., Mordoh, J., Bianchini, M."Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells". Oncology Reports 37, no. 5 (2017): 2633-2651. https://doi.org/10.3892/or.2017.5547